Report Detail
Global Model Species Market Growth (Status and Outlook) 2022-2028
- RnM4484367 |
- 22 August, 2022 |
- Global |
- 110 Pages |
- LPI(LP Information) |
- Other
The global market for Model Species is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Model Species market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Model Species market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Model Species market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Model Species market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Model Species players cover Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories, Envigo and Taconic Biosciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Model Species market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Model Species market, with both quantitative and qualitative data, to help readers understand how the Model Species market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Model Species market and forecasts the market size by Type (Rat, Mouse and Zebrafish), by Application (Drug Discovery, Basic Research, Toxicity Test and Parasitological Study), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Rat
Mouse
Zebrafish
Arabidopsis Thaliana
Others
Segmentation by application
Drug Discovery
Basic Research
Toxicity Test
Parasitological Study
Hereditary Disease Study
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Shanghai Model Organisms Center, Inc.
Gem Pharmatech Co., Ltd.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Shanghai SLAC
Joinn Laboratories
Crown Biosciences
Pharmalegacy
Syngene International
Janvier Labs
GenOway
Psychogenics
Horizon Discovery Group
Vitalstar Biotechnology
Chapter Introduction
Chapter 1: Scope of Model Species, Research Methodology, etc.
Chapter 2: Executive Summary, global Model Species market size and CAGR, Model Species market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Model Species revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Model Species revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Model Species market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Shanghai SLAC, Joinn Laboratories and Crown Biosciences, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Model Species Market Size 2017-2028
- 2.1.2 Model Species Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Model Species Segment by Type
- 2.2.1 Rat
- 2.2.2 Mouse
- 2.2.3 Zebrafish
- 2.2.4 Arabidopsis Thaliana
- 2.2.5 Others
- 2.3 Model Species Market Size by Type
- 2.3.1 Model Species Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Model Species Market Size Market Share by Type (2017-2022)
- 2.4 Model Species Segment by Application
- 2.4.1 Drug Discovery
- 2.4.2 Basic Research
- 2.4.3 Toxicity Test
- 2.4.4 Parasitological Study
- 2.4.5 Hereditary Disease Study
- 2.5 Model Species Market Size by Application
- 2.5.1 Model Species Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Model Species Market Size Market Share by Application (2017-2022)
3 Model Species Market Size by Player
- 3.1 Model Species Market Size Market Share by Players
- 3.1.1 Global Model Species Revenue by Players (2020-2022)
- 3.1.2 Global Model Species Revenue Market Share by Players (2020-2022)
- 3.2 Global Model Species Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Model Species by Regions
- 4.1 Model Species Market Size by Regions (2017-2022)
- 4.2 Americas Model Species Market Size Growth (2017-2022)
- 4.3 APAC Model Species Market Size Growth (2017-2022)
- 4.4 Europe Model Species Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Model Species Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Model Species Market Size by Country (2017-2022)
- 5.2 Americas Model Species Market Size by Type (2017-2022)
- 5.3 Americas Model Species Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Model Species Market Size by Region (2017-2022)
- 6.2 APAC Model Species Market Size by Type (2017-2022)
- 6.3 APAC Model Species Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Model Species by Country (2017-2022)
- 7.2 Europe Model Species Market Size by Type (2017-2022)
- 7.3 Europe Model Species Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Model Species by Region (2017-2022)
- 8.2 Middle East & Africa Model Species Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Model Species Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Model Species Market Forecast
- 10.1 Global Model Species Forecast by Regions (2023-2028)
- 10.1.1 Global Model Species Forecast by Regions (2023-2028)
- 10.1.2 Americas Model Species Forecast
- 10.1.3 APAC Model Species Forecast
- 10.1.4 Europe Model Species Forecast
- 10.1.5 Middle East & Africa Model Species Forecast
- 10.2 Americas Model Species Forecast by Country (2023-2028)
- 10.2.1 United States Model Species Market Forecast
- 10.2.2 Canada Model Species Market Forecast
- 10.2.3 Mexico Model Species Market Forecast
- 10.2.4 Brazil Model Species Market Forecast
- 10.3 APAC Model Species Forecast by Region (2023-2028)
- 10.3.1 China Model Species Market Forecast
- 10.3.2 Japan Model Species Market Forecast
- 10.3.3 Korea Model Species Market Forecast
- 10.3.4 Southeast Asia Model Species Market Forecast
- 10.3.5 India Model Species Market Forecast
- 10.3.6 Australia Model Species Market Forecast
- 10.4 Europe Model Species Forecast by Country (2023-2028)
- 10.4.1 Germany Model Species Market Forecast
- 10.4.2 France Model Species Market Forecast
- 10.4.3 UK Model Species Market Forecast
- 10.4.4 Italy Model Species Market Forecast
- 10.4.5 Russia Model Species Market Forecast
- 10.5 Middle East & Africa Model Species Forecast by Region (2023-2028)
- 10.5.1 Egypt Model Species Market Forecast
- 10.5.2 South Africa Model Species Market Forecast
- 10.5.3 Israel Model Species Market Forecast
- 10.5.4 Turkey Model Species Market Forecast
- 10.5.5 GCC Countries Model Species Market Forecast
- 10.6 Global Model Species Forecast by Type (2023-2028)
- 10.7 Global Model Species Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Shanghai Model Organisms Center, Inc.
- 11.1.1 Shanghai Model Organisms Center, Inc. Company Information
- 11.1.2 Shanghai Model Organisms Center, Inc. Model Species Product Offered
- 11.1.3 Shanghai Model Organisms Center, Inc. Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Shanghai Model Organisms Center, Inc. Main Business Overview
- 11.1.5 Shanghai Model Organisms Center, Inc. Latest Developments
- 11.2 Gem Pharmatech Co., Ltd.
- 11.2.1 Gem Pharmatech Co., Ltd. Company Information
- 11.2.2 Gem Pharmatech Co., Ltd. Model Species Product Offered
- 11.2.3 Gem Pharmatech Co., Ltd. Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Gem Pharmatech Co., Ltd. Main Business Overview
- 11.2.5 Gem Pharmatech Co., Ltd. Latest Developments
- 11.3 Charles River Laboratories
- 11.3.1 Charles River Laboratories Company Information
- 11.3.2 Charles River Laboratories Model Species Product Offered
- 11.3.3 Charles River Laboratories Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Charles River Laboratories Main Business Overview
- 11.3.5 Charles River Laboratories Latest Developments
- 11.4 Envigo
- 11.4.1 Envigo Company Information
- 11.4.2 Envigo Model Species Product Offered
- 11.4.3 Envigo Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Envigo Main Business Overview
- 11.4.5 Envigo Latest Developments
- 11.5 Taconic Biosciences
- 11.5.1 Taconic Biosciences Company Information
- 11.5.2 Taconic Biosciences Model Species Product Offered
- 11.5.3 Taconic Biosciences Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Taconic Biosciences Main Business Overview
- 11.5.5 Taconic Biosciences Latest Developments
- 11.6 Jackson Laboratory
- 11.6.1 Jackson Laboratory Company Information
- 11.6.2 Jackson Laboratory Model Species Product Offered
- 11.6.3 Jackson Laboratory Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Jackson Laboratory Main Business Overview
- 11.6.5 Jackson Laboratory Latest Developments
- 11.7 Shanghai SLAC
- 11.7.1 Shanghai SLAC Company Information
- 11.7.2 Shanghai SLAC Model Species Product Offered
- 11.7.3 Shanghai SLAC Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Shanghai SLAC Main Business Overview
- 11.7.5 Shanghai SLAC Latest Developments
- 11.8 Joinn Laboratories
- 11.8.1 Joinn Laboratories Company Information
- 11.8.2 Joinn Laboratories Model Species Product Offered
- 11.8.3 Joinn Laboratories Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Joinn Laboratories Main Business Overview
- 11.8.5 Joinn Laboratories Latest Developments
- 11.9 Crown Biosciences
- 11.9.1 Crown Biosciences Company Information
- 11.9.2 Crown Biosciences Model Species Product Offered
- 11.9.3 Crown Biosciences Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Crown Biosciences Main Business Overview
- 11.9.5 Crown Biosciences Latest Developments
- 11.10 Pharmalegacy
- 11.10.1 Pharmalegacy Company Information
- 11.10.2 Pharmalegacy Model Species Product Offered
- 11.10.3 Pharmalegacy Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Pharmalegacy Main Business Overview
- 11.10.5 Pharmalegacy Latest Developments
- 11.11 Syngene International
- 11.11.1 Syngene International Company Information
- 11.11.2 Syngene International Model Species Product Offered
- 11.11.3 Syngene International Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Syngene International Main Business Overview
- 11.11.5 Syngene International Latest Developments
- 11.12 Janvier Labs
- 11.12.1 Janvier Labs Company Information
- 11.12.2 Janvier Labs Model Species Product Offered
- 11.12.3 Janvier Labs Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Janvier Labs Main Business Overview
- 11.12.5 Janvier Labs Latest Developments
- 11.13 GenOway
- 11.13.1 GenOway Company Information
- 11.13.2 GenOway Model Species Product Offered
- 11.13.3 GenOway Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 GenOway Main Business Overview
- 11.13.5 GenOway Latest Developments
- 11.14 Psychogenics
- 11.14.1 Psychogenics Company Information
- 11.14.2 Psychogenics Model Species Product Offered
- 11.14.3 Psychogenics Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Psychogenics Main Business Overview
- 11.14.5 Psychogenics Latest Developments
- 11.15 Horizon Discovery Group
- 11.15.1 Horizon Discovery Group Company Information
- 11.15.2 Horizon Discovery Group Model Species Product Offered
- 11.15.3 Horizon Discovery Group Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Horizon Discovery Group Main Business Overview
- 11.15.5 Horizon Discovery Group Latest Developments
- 11.16 Vitalstar Biotechnology
- 11.16.1 Vitalstar Biotechnology Company Information
- 11.16.2 Vitalstar Biotechnology Model Species Product Offered
- 11.16.3 Vitalstar Biotechnology Model Species Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 Vitalstar Biotechnology Main Business Overview
- 11.16.5 Vitalstar Biotechnology Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Model Species. Industry analysis & Market Report on Model Species is a syndicated market report, published as Global Model Species Market Growth (Status and Outlook) 2022-2028
. It is complete Research Study and Industry Analysis of Model Species market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
